tern as evaluative tool in diagnosis of urogenital cell proliferative disordersUS7838307 *8 Dec 200523 Nov 2010Lyotropic Therapeutics, Inc.binding to assay substrata in a stable and protective manner thereby enhancing assay performance; provides compositions of lyotropic liquid and/or, preferably, liquid crystalline materials capable of binding to assay substrata, including compositions containing